Elastografía transicional (Fibroscan®): nuevo método para la evaluación no invasiva de la fibrosis hepática
DOI:
https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v31i4.958Resumen
.
Descargas
Referencias
Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol. 2006;18(4):411-2. DOI: https://doi.org/10.1097/00042737-200604000-00015
Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weak-er sex? Hepatology. 2006;44(2):513-4. DOI: https://doi.org/10.1002/hep.21306
Wong VW, Vergniol J, Wong GL, et al. Diag-nosis of fibrosis and cirrhosis using liver stiff-ness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51(2):454-62.
Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central ve-nous pressure. J Hepatol. 2010;52(2):206-10. DOI: https://doi.org/10.1016/j.jhep.2009.11.018
Fraquelli M, Rigamonti C, Casazza G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56(7):968-73 DOI: https://doi.org/10.1136/gut.2006.111302
Poynard T, Halfon P, Castera L. Variability of the area under the receiver operating char-acteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther. 2007;25(6):733-9. DOI: https://doi.org/10.1111/j.1365-2036.2007.03252.x
Castera L, Vergniol J, Foucher J, et al. Pro-spective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the as-sessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343-50. DOI: https://doi.org/10.1053/j.gastro.2004.11.018
Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008; 134(4):960-74. DOI: https://doi.org/10.1053/j.gastro.2008.01.034
Vergniol J, De Ledinghen V. Diagnostic non invasif de la fibrose hépatique: modalités pratiques d’utilisation des marqueurs sanguins et du FibroScan. Non-invasive diagnosis of liv-er fibrosis: guidelines for the use of biomark-ers and FibroScan. Gastroenterol Clin Biol. 2009;33(4):334-44. DOI: https://doi.org/10.1016/j.gcb.2009.02.014
Marcellin P, Ziol M, Bedossa. Non-invasive assessment of liver fibrosis by stiffness mea-surement in patients with chronic hepatitis B. Liver Int. 2009; 29(2):242-7. DOI: https://doi.org/10.1111/j.1478-3231.2008.01802.x
Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by tran-sient elastography in patients with PBC and PSC. Hepatology. 2006;43(5):1118-24 DOI: https://doi.org/10.1002/hep.21151
Wong V, Vergniol J, Wong G, et al. Diag-nosis of fibrosis and cirrhosis using liver stiff-ness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51(2):454-62. DOI: https://doi.org/10.1002/hep.23312
Kazemi F, Kettaneh A, N’Kontchou G, et al. Liver stiffness measurement se-lects patients with cirrhosis at risk of bear-ing large oesophageal varices. J Hepatol. 2006;45:230-5. DOI: https://doi.org/10.1016/j.jhep.2006.04.006
Mauss S. Treatment of viral hepatitis in HIV-coinfected patients adverse events and their management. J Hepatol 2006; 44(1 suppl):S114-8. DOI: https://doi.org/10.1016/j.jhep.2005.11.024
Pineda JA, Recio E, Camacho A, et al. Liver stiffness as a predictor of esopha-geal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis. J Acquir Immune Defic Syndr. 2009;51(4):445-9. DOI: https://doi.org/10.1097/QAI.0b013e3181acb675
Descargas
Compartir artículo
Publicado
Número
Sección
Licencia
Derechos de autor 2011 Revista del Hospital Italiano de Buenos Aires
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
